Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • CDSCO

    Tag: cdsco

    You Searched For "CDSCO"
    CDSCO Committee rejects proposal for additional Indications of Dapaglofizin

    CDSCO Committee rejects proposal for additional Indications of Dapaglofizin

    Meghna A Singhania5 May 2019 12:52 PM IST
    New Delhi: British-Swedish multinational drugmaker, AstraZeneca's stride to win approval from the Indian drug regulators for the additional...
    Union Health Minister asked not to receive donations from JnJ for TB Control Program

    Union Health Minister asked not to receive donations from JnJ for TB Control Program

    Medical Dialogues Bureau3 May 2019 9:15 AM IST
    Recently, Johnson & Johnson (JnJ) had announced to provide an additional 10,000 courses of tuberculosis drug bedaquiline (BDQ) to the Indian...
    Glenmark launches SGLT2 Inhibitor Remogliflozin under brand names Remo, Remozen

    Glenmark launches SGLT2 Inhibitor Remogliflozin under brand names Remo, Remozen

    Meghna A Singhania30 April 2019 10:16 AM IST
    Glenmark will commercialize Remogliflozin in India under the brand names 'Remo' and 'Remozen'.Mumbai: In a major relief to diabetics, Glenmark...
    CDSCO approves Zydus, SIFI pact to launch Intraocular Lenses in India

    CDSCO approves Zydus, SIFI pact to launch Intraocular Lenses in India

    Farhat Nasim30 April 2019 10:15 AM IST
    "SIFI's innovative IOLs (Intraocular lenses) have been approved by the Indian Central Drugs Standards Control Organisation(CDSCO) (Directorate General...
    CDSCO to hire 754 Regulatory Officers especially to regulate Medical Devices in country:DTAB

    CDSCO to hire 754 Regulatory Officers especially to regulate Medical Devices in country:DTAB

    Meghna A Singhania27 April 2019 3:00 PM IST
    New Delhi: With the various controversies relating to medical devices taking the limelight, the Government is looking forward to recruiting 754...
    Drugs registered on SUGAM portal to be exempted from obtaining licence for purpose of examination, test, analysis

    Drugs registered on SUGAM portal to be exempted from obtaining licence for purpose of examination, test, analysis

    Meghna A Singhania21 April 2019 2:26 PM IST
    The exemption from obtaining a licence for Form 29 is subject to the condition that the information about the manufacturing of approved drugs for...
    Chemists and Druggists or Pharmacy? DTAB decides on nomenclature

    Chemists and Druggists or Pharmacy? DTAB decides on nomenclature

    Meghna A Singhania20 April 2019 11:44 AM IST
    New Delhi: The highest statutory decision-making body under CDSCO, Drug Technical Advisory Board (DTAB) has given its in principal nod to replace the...
    Government to revise limit of free salicylic acid content in drugs containing ASPIRIN

    Government to revise limit of free salicylic acid content in drugs containing ASPIRIN

    Meghna A Singhania18 April 2019 3:13 PM IST
    New Delhi: Government is soon going to revise the limit of free salicylic acid content in medicines containing Aspirin, as the Drugs and Techincal...
    All medical devices sold in India to be CDSCO certified: What is Means

    All medical devices sold in India to be CDSCO certified: What is Means

    Meghna A Singhania18 April 2019 2:59 PM IST
    Once this notification comes into effect, the manufacture and sale of all medical devices would have to be certified by the Central Drugs Standard...
    Adverse Reactions: Cefotaxime, Oflaxicin, Cefixime told to carry Warning by CDSCO

    Adverse Reactions: Cefotaxime, Oflaxicin, Cefixime told to carry Warning by CDSCO

    Meghna A Singhania17 April 2019 12:26 PM IST
    New Delhi: The national regulatory body for Indian Pharmaceutical and Medical Device, Central Drugs Standard Control Organisation (CDSCO) has ordered...
    CDSCO expert committee suggests ban of yet another 324 FDCs

    CDSCO expert committee suggests ban of yet another 324 FDCs

    Meghna A Singhania15 April 2019 11:49 AM IST
    New Delhi: Domestic drugmakers are likely to face a blow as 324 Fixed Dose Combination (FDCs) drugs have been recommended to be banned by an expert...
    Upload application in SUGAM as per new Rules: CDSCO issues notice

    Upload application in SUGAM as per new Rules: CDSCO issues notice

    Meghna A Singhania13 April 2019 1:39 PM IST
    New Delhi: Through a recent notice, the Central Drugs Standard Control Organization (CDSCO) has informed that uploading of applications through SUGAM...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok